Preliminary Functional Results and Quality of Life After Implantation of a New Bone Conduction Hearing Device in Patients With Conductive and Mixed Hearing Loss

Ihler, Friedrich; Volbers, Laura; Blum, J.; Matthias, Christoph; Canis, Martin

doi:10.1097/mao.0000000000000208

Cited by 65 publications

(67 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A total of 12 studies have assessed safety outcomes with the Bonebridge in a total of 117 patients. Nine papers reported no adverse events over a postoperative course of at least 6 months.…”

Section: Safety Outcomes With the Bonebridgementioning

confidence: 99%

The Bonebridge Bone Conduction Hearing Implant: indication criteria, surgery and a systematic review of the literature

Sprinzl

Wolf‐Magele

2016

Clinical Otolaryngology

125

105

View full text Add to dashboard Cite

The transcutaneous BCI system Bonebridge provides a valuable and stable audiological benefit to patients suffering from conductive or mixed hearing loss and SSD. With its active transcutaneous design, the Bonebridge offers a lower complication rate to percutaneous systems and higher and more reliable hearing gain compared to other transcutaneous or percutaneous systems. Moreover, the fast activation of the implant system enables the recipient of the system to benefit in a short time frame postoperatively from the intervention.

show abstract

Section: Safety Outcomes With the Bonebridgementioning

confidence: 99%

The Bonebridge Bone Conduction Hearing Implant: indication criteria, surgery and a systematic review of the literature

Sprinzl

Wolf‐Magele

2016

Clinical Otolaryngology

125

105

View full text Add to dashboard Cite

show abstract

“…The Glasgow Health Status Inventory (GHSI) and the Glasgow Benefit Inventory (GBI) were used to measure the preoperative effect of hearing loss on the quality of life and the change in health status produced by the surgical intervention, respectively [8]. Both the GBI and the GHSI are composed of 18 questions.…”

Section: Methodsmentioning

confidence: 99%

“…The total score was divided by the number of questions, then multiplied by 50 after subtracting 3, thus yielding a final score between 0 and +100. Subscale scores were also assessed (general overview as well as social and physical scores) [8]. …”

Section: Methodsmentioning

confidence: 99%

“…With dedicated software, the positioning of the BC-FMT can be planned in order to avoid any compression of the sinus and dura, and to locate the screws on the same plane [6,7]. In case of atresia auris, where a pinna reconstruction is planned at a later stage, the incision should be done further posteriorly [8. ]In the classic location, the BC-FMT is placed near the sinodural angle anterior to the sigmoid sinus (presigmoid).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Active Bone Conduction System: Outcomes with the Bonebridge Transcutaneous Device

Bianchin

Bonali

Russo

et al. 2015

ORL

View full text Add to dashboard Cite

Objective: To describe our experience with positioning the Bonebridge (BB) device, a semi-implantable transcutaneous bone conduction implant for patients with conductive and mixed hearing loss as well as for those suffering from single-sided deafness. Methods: The following is a retrospective case review of 4 adults suffering from conductive or mixed hearing loss and single-sided deafness. The BB device was implanted unilaterally via 2 different approaches selected case by case: the presigmoid transmastoid and the retrosigmoid approach. An audiological evaluation in the free field was conducted to observe the functional benefit with this device. The Glasgow Health Status Inventory (GHSI) and the Glasgow Benefit Inventory (GBI) questionnaires were filled out to evaluate patients' quality of life in relationship to the intervention. Results: No intra- or postoperative complications were observed. The performance in the speech test in all 4 cases reached 100% in the aided condition at 65 dB, while in the unaided condition at 65 dB, it was less than 10%. The GHSI and GBI questionnaires showed an improvement in quality of life after implantation. Conclusions: The BB device is a safe and effective solution for individuals with pathologies such as chronic otitis media, atresia auris and otosclerosis with inadequate benefit from conventional surgery or bone conduction hearing aids.

show abstract

“…In an experimental cadaver study (17), noninferiority of the BB in comparison with a percutaneous BC device (pBCD), the BAHA (Cochlear Bone Anchored Solutions AG, Mölnlycke, Sweden), was shown for both, the stimulation of the same-sided cochlea as well as the opposite cochlea for promontory vibration. Clinically, tBCDs have been used primarily for resolution of conductive and mixed hearing loss (20).…”

mentioning

confidence: 99%

Functional Results and Subjective Benefit of a Transcutaneous Bone Conduction Device in Patients With Single-Sided Deafness

Laske

Röösli

Pfiffner

et al. 2015

Otology &Amp; Neurotology

View full text Add to dashboard Cite

Preliminary Functional Results and Quality of Life After Implantation of a New Bone Conduction Hearing Device in Patients With Conductive and Mixed Hearing Loss

Abstract: Audiometric results of the new bone conduction hearing system are satisfying and comparable to the results of devices that have been applied previously for CHL and MHL. Intraoperatively and postoperatively, no complications were noted.

Cited by 65 publications

References 13 publications

The Bonebridge Bone Conduction Hearing Implant: indication criteria, surgery and a systematic review of the literature

The Bonebridge Bone Conduction Hearing Implant: indication criteria, surgery and a systematic review of the literature

Active Bone Conduction System: Outcomes with the Bonebridge Transcutaneous Device

Functional Results and Subjective Benefit of a Transcutaneous Bone Conduction Device in Patients With Single-Sided Deafness

Contact Info

Product

Resources

About